Skip Navigation
 

Funding


RCDC

Project Listing by Category


Back to Estimates of Funding for Various Research, Condition, and Disease Categories (RCDC) Click the column headings to sort project listings.
  Help
12345678910...
CategoryFYFunding ICProject NumberSub Project #Project TitlePI NameOrg NameState / CountryAmount
Emerging Infectious Diseases 2017 NIAID NIH-17-035 ASPR $45,000
Emerging Infectious Diseases 2017 NIAID 1R01AI121054-01 Understanding measles vaccine failure (and success) in Southern India KENNEDY, RICHARD MAYO CLINIC ROCHESTER MN $807,900
Emerging Infectious Diseases 2017 NICHD 5R01HD074944-03 Innovative PK/PD Approaches to Optimize TBM Treatment in Children (PATCH Study) DOOLEY, KELLY JOHNS HOPKINS UNIVERSITY MD $500,491
Emerging Infectious Diseases 2017 NIAID 1K22AI123465-01 Community behavior of Yersinia pseudotuberculosis within microcolonies DAVIS, KIM JOHNS HOPKINS UNIVERSITY MD $162,000
Emerging Infectious Diseases 2017 NIAID 1K22AI123467-01 Structural Basis of Type IV Pilus-Induced Clostridium difficile Microcolony Formation PIEPENBRINK, KURT UNIVERSITY OF NEBRASKA LINCOLN NE $153,360
Emerging Infectious Diseases 2017 NIAID 1K22AI123478-01 Co-engaging CD23 and BCR for enhanced neutralizing antibody responses WANG, TAIA STANFORD UNIVERSITY CA $160,946
Emerging Infectious Diseases 2017 NIAID 5F32AI120579-02 Elucidating the diverse roles of noncoding small RNAs in chikungunya virus infection ROZEN-GAGNON, KATHRYN ROCKEFELLER UNIVERSITY NY $56,694
Emerging Infectious Diseases 2017 NCI 5F30CA180731-03 TCR Gene Transfer for Treating HCV-Associated Malignancies SPEAR, TIMOTHY LOYOLA UNIVERSITY CHICAGO IL $49,044
Emerging Infectious Diseases 2017 NIAID 4R37AI048071-16 Mapping Drug Resistance Genes in Plasmodium falciparum ANDERSON, TIM TEXAS BIOMEDICAL RESEARCH INSTITUTE TX $923,047
Emerging Infectious Diseases 2017 NHLBI 5R01HL129887-02 Anti-TB sterilizing immunity in immune and HIV+ individuals CHEN, ZHENG UNIVERSITY OF ILLINOIS AT CHICAGO IL $674,207
Emerging Infectious Diseases 2017 NIAID 2R37AI101935-06 Inflammatory Caspases in Innate Immunity and Inflammation KANNEGANTI, THIRUMALA-DEVI ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $448,750
Emerging Infectious Diseases 2017 NIAMS 5R03AR066366-03 Load Bearing 3D Printed Implants for Antibiotic, Cell and Growth Factory Delivery FALCE, CHRISTINE OXFORD PERFORMANCE MATERIALS, INC. CT $1
Emerging Infectious Diseases 2017 NIAID 1R43AI122551-01A1 A mucosally targeted MERS-CoV vaccine produced in plants WYCOFF, KEITH PLANET BIOTECHNOLOGY, INC. CA $236,488
Emerging Infectious Diseases 2017 NIDA 5U01DA040381-02 Cohort Studies on HIV/AIDS and Substance Abuse in Miami BAUM, MARIANNA FLORIDA INTERNATIONAL UNIVERSITY FL $1,077,827
Emerging Infectious Diseases 2017 NIBIB 5R01EB021900-02 SCH: INT A.Soclotechnilcal Systems Systems Approach for Improving Tuberculosis Diagnostics Using Mobile Health Technologies BRUNETTE, MARIA UNIVERSITY OF MASSACHUSETTS LOWELL MA $326,571
Emerging Infectious Diseases 2017 NIGMS 1R01GM120594-01 Structural and Mechanistic Characterization of MraY Catalysis and Inhibition LEE, SEOK-YONG DUKE UNIVERSITY NC $342,648
Emerging Infectious Diseases 2017 NIAID 1K22AI125473-01 Uncovering new mechanisms of nematode anthelmintic resistance ZAMANIAN, MOSTAFA UNIVERSITY OF WISCONSIN-MADISON WI $160,800
Emerging Infectious Diseases 2017 NIAID 1K22AI125501-01 Investigating S. aureus persister formation under physiological conditions CONLON, BRIAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $161,680
Emerging Infectious Diseases 2017 NIAID 5R01AI045135-14 Functional analysis of flavivirus genetic resistance BRINTON, MARGO GEORGIA STATE UNIVERSITY GA $399,885
Emerging Infectious Diseases 2017 NIAID 5R01AI095753-04 Effects of Arboviral Population Diversity on Transmission FORRESTER, NAOMI UNIVERSITY OF TEXAS MED BR GALVESTON TX $387,500
Emerging Infectious Diseases 2017 NIAID 5R01AI105191-04 Functional Analysis of the T. gondii AMA1 Cytosolic Tail WARD, GARY UNIVERSITY OF VERMONT & ST AGRIC COLLEGE VT $381,250
Emerging Infectious Diseases 2017 NIAID 5R01AI114699-03 Innate immune responses to malaria liver stage infection KAPPE, STEFAN SEATTLE BIOMEDICAL RESEARCH INSTITUTE WA $472,500
Emerging Infectious Diseases 2017 NIAID 5R01AI050113-13 Structure, function, and evolution of the Cryptococcus MAT locus HEITMAN, JOSEPH DUKE UNIVERSITY NC $431,040
Emerging Infectious Diseases 2017 NIAID 5R01AI107123-04 Biogenesis of the Poxvirus Membrane TRAKTMAN, PAULA MEDICAL UNIVERSITY OF SOUTH CAROLINA SC $373,750
Emerging Infectious Diseases 2017 NIAID 5R01AI109008-05 Origin of the innate immunity suppression caused by nairovirus' protease activity PEGAN, SCOTT UNIVERSITY OF GEORGIA GA $308,767
Emerging Infectious Diseases 2017 NIAID 5R01AI110703-03 Quantifying Environmental Variables Affecting Airborne Influenza Transmission BOUVIER, NICOLE ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $394,281
Emerging Infectious Diseases 2017 NIAID 5R01AI115471-03 Gamma Delta T cell surveillance of metabolites as signals of cellular stress ADAMS, ERIN UNIVERSITY OF CHICAGO IL $389,432
Emerging Infectious Diseases 2017 NIAID 5R01AI114655-03 Effector diversification and Toxoplasma virulence BOYLE, JON UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $361,511
Emerging Infectious Diseases 2017 NIAID 5R01AI116059-03 Mechanisms of persistent Salmonella infection MONACK, DENISE STANFORD UNIVERSITY CA $400,633
Emerging Infectious Diseases 2017 NIAID 5R01AI105114-04 Viral Interface with an Interferon-Induced Gene REICH, NANCY STATE UNIVERSITY NEW YORK STONY BROOK NY $463,541
Emerging Infectious Diseases 2017 NIAID 5R01AI079243-09 MicroRNA Function in the Immune System BALTIMORE, DAVID CALIFORNIA INSTITUTE OF TECHNOLOGY CA $416,250
Emerging Infectious Diseases 2017 NIDCD 5R01DC013587-04 Functional analysis of insect taste receptors DAHANUKAR, ANUPAMA UNIVERSITY OF CALIFORNIA RIVERSIDE CA $360,293
Emerging Infectious Diseases 2017 NIAID 5R01AI114543-03 Memory CD8 T cell localization and protection from influenza HARTY, JOHN UNIVERSITY OF IOWA IA $381,250
Emerging Infectious Diseases 2017 NIAID 5R01AI114748-03 miRNA-mediated premature T cell aging in vaccine failure during viral infection YAO, ZHI EAST TENNESSEE STATE UNIVERSITY TN $365,000
Emerging Infectious Diseases 2017 NIAID 5R01AI033325-22 Long Term Immunity against Toxoplasmosis KHAN, IMTIAZ GEORGE WASHINGTON UNIVERSITY DC $396,250
Emerging Infectious Diseases 2017 NIAID 5R01AI120987-02 Metallopolymer and Antibiotic Bioconjugates against Multidrug Resistant Bacteria TANG, CHUANBING UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA SC $361,600
Emerging Infectious Diseases 2017 NIAID 5R01AI102888-04 Foxo1-dependent Programme in the Control of Regulatory T Cell Function LI, MING SLOAN-KETTERING INST CAN RESEARCH NY $432,133
Emerging Infectious Diseases 2017 NIAID 5F31AI116028-03 Analysis Of Influenza Virus Polymerase Interactions With The Host Transcriptome PERALTA, ZULEYMA ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $38,489
Emerging Infectious Diseases 2017 NIAID 5R01AI105068-04 Nuclear MT1-MMP and Macrophage Immune Function WEISS, STEPHEN UNIVERSITY OF MICHIGAN MI $388,750
Emerging Infectious Diseases 2017 NIAID 5R01AI038897-22 Surface Proteins of Gram-Positive Bacteria SCHNEEWIND, OLAF UNIVERSITY OF CHICAGO IL $389,432
Emerging Infectious Diseases 2017 NIAID 5F31AI115931-03 The role of the Unfolded Protein Response in Brucella melitensis replication KHAN, MEKAIL UNIVERSITY OF WISCONSIN-MADISON WI $31,900
Emerging Infectious Diseases 2017 NIAID 5K23AI114994-03 Rapid Identification of Neutropenic Patients at High Risk of CRE Bacteremia SATLIN, MICHAEL WEILL MEDICAL COLL OF CORNELL UNIV NY $191,015
Emerging Infectious Diseases 2017 NIAID 5R01AI070759-09 CATABOLITE REPRESSION CONTROLS VIRULENCE IN STREPTOCOCCUS PYOGENES CAPARON, MICHAEL WASHINGTON UNIVERSITY MO $342,000
Emerging Infectious Diseases 2017 NIAID 5R01AI102942-06 Regulation and function of innate lymphoid cells during influenza virus infection ARTIS, DAVID WEILL MEDICAL COLL OF CORNELL UNIV NY $423,750
Emerging Infectious Diseases 2017 NIDCD 5R01DC014247-03 Neuropeptide Regulation of Mosquito Host-Seeking Behavior VOSSHALL, LESLIE ROCKEFELLER UNIVERSITY NY $360,188
Emerging Infectious Diseases 2017 NIAID 5R01AI105147-03 Database designed novel anti-MRSA peptides WANG, GUANGSHUN UNIVERSITY OF NEBRASKA MEDICAL CENTER NE $376,250
Emerging Infectious Diseases 2017 NIAID 5R01AI121124-02 Infectious Entry Mechanisms of Obligatory Intracellular Pathogen RIKIHISA, YASUKO OHIO STATE UNIVERSITY OH $385,000
Emerging Infectious Diseases 2017 NIAID 5R01AI015608-36 Cytotoxic T Lymphocyte Response to Influenza Virus BRACIALE, THOMAS UNIVERSITY OF VIRGINIA VA $395,000
Emerging Infectious Diseases 2017 NIAID 5R01AI110201-04 IL-27 and Treg cells HUNTER, CHRISTOPHER UNIVERSITY OF PENNSYLVANIA PA $400,000
Emerging Infectious Diseases 2017 NIAID 5R01AI105129-04 Contribution of LukED to Staphylococcus aureus pathobiology TORRES, VICTOR NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $426,100
Emerging Infectious Diseases 2017 NIAID 5R01AI117911-02 C. elegans to study organismal control of recovery from bacterial infections ABALLAY, ALEJANDRO DUKE UNIVERSITY NC $394,588
Emerging Infectious Diseases 2017 NIAID 5K01AI110526-03 Identifying Transmission Routes for Cholera among Household Contacts of Cases GEORGE, CHRISTINE JOHNS HOPKINS UNIVERSITY MD $135,932
Emerging Infectious Diseases 2017 NIAID 5F32AI114094-03 CDI System-mediated Intra- and Inter-species Interactions in Burkholderia BARRERO-TOBON, ANGELICA UNIV OF NORTH CAROLINA CHAPEL HILL NC $57,066
Emerging Infectious Diseases 2017 NIGMS 2R01GM057454-18 Molecular Mechanisms of Alphavirus Entry and Exit KIELIAN, MARGARET ALBERT EINSTEIN COLLEGE OF MEDICINE, INC NY $417,500
Emerging Infectious Diseases 2017 NIAID 5UM1AI069415-12 Integrated University of Puerto Rico Clinical Trials Unit ZORRILLA, CARMEN UNIVERSITY OF PUERTO RICO MED SCIENCES PR $1,139,676
Emerging Infectious Diseases 2017 NIAID 5R01AI114701-03 The effect of binding of fH to meningococcal fHbp vaccine on antibody protection GRANOFF, DAN CHILDREN'S HOSPITAL & RES CTR AT OAKLAND CA $627,269
Emerging Infectious Diseases 2017 NIAID 5R01AI042135-19 Innate Immune Responses to Microbial Flora PAMER, ERIC SLOAN-KETTERING INST CAN RESEARCH NY $481,456
Emerging Infectious Diseases 2017 NIAID 5R01AI114511-03 Tryptophan derivatives in EHEC pathogenesis SPERANDIO, VANESSA UT SOUTHWESTERN MEDICAL CENTER TX $458,512
Emerging Infectious Diseases 2017 NIAID 5R01AI121386-02 Targeting Innate Immunity in Staphylococcal Infection GERARD, NORMA BOSTON CHILDREN'S HOSPITAL MA $442,500
Emerging Infectious Diseases 2017 NIAID 5R01AI120625-02 Molecular Regulation of Systemic Inflammation STEHLIK, CHRISTIAN NORTHWESTERN UNIVERSITY AT CHICAGO IL $386,250
Emerging Infectious Diseases 2017 NIGMS 5R01GM034496-33 Regulation of lipid metabolism in bacteria ROCK, CHARLES ST. JUDE CHILDREN'S RESEARCH HOSPITAL TN $735,950
Emerging Infectious Diseases 2017 NIGMS 5R01GM112739-03 Comprehensive analysis of NRPS-derived metabolomes of three Aspergillus species KELLER, NANCY UNIVERSITY OF WISCONSIN-MADISON WI $279,388
Emerging Infectious Diseases 2017 NIAID 5UM1AI069501-11 Case Clinical Trials Unit LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $1,874,344
Emerging Infectious Diseases 2017 OD 5UM1AI069501-11 Case Clinical Trials Unit LEDERMAN, MICHAEL CASE WESTERN RESERVE UNIVERSITY OH $103,025
Emerging Infectious Diseases 2017 NIAID 5R01AI051486-14 Regulation of gene expression in Borrelia burgdorferi SAMUELS, D. UNIVERSITY OF MONTANA MT $353,750
Emerging Infectious Diseases 2017 NIAID 5R01AI121285-02 Studies of IGHV Germline Gene Polymorphism, Utilization & Shifting for Seasonal Influenza Vaccine Induced Broadly Neutralizing Antibody Responses MARASCO, WAYNE DANA-FARBER CANCER INST MA $834,149
Emerging Infectious Diseases 2017 NIAID 5R01AI121354-02 The necrosis-inducing toxin of Mycobacterium tuberculosis NIEDERWEIS, MICHAEL UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $534,163
Emerging Infectious Diseases 2017 NIAID 5R01AI060584-11 Parameters governing infection with BK polyomavirus IMPERIALE, MICHAEL UNIVERSITY OF MICHIGAN MI $381,175
Emerging Infectious Diseases 2017 NIAID 5R01AI060767-11 Targeting of host vesicles to the vacuole of Toxoplasma and lipid cargo sorting COPPENS, ISABELLE JOHNS HOPKINS UNIVERSITY MD $405,000
Emerging Infectious Diseases 2017 NIAID 5R01AI103267-04 Coordinated stationary phase control of Campylobacter motility and biofilm THOMPSON, STUART AUGUSTA UNIVERSITY GA $300,000
Emerging Infectious Diseases 2017 NIAID 5R21AI121552-02 Bacteriophage to prevent infection by antibiotic-resistant enterococci KRISTICH, CHRISTOPHER MEDICAL COLLEGE OF WISCONSIN WI $188,330
Emerging Infectious Diseases 2017 NIAID 5R44AI100401-05 Broad Spectrum Antiviral Nucleoside Phosphonate Analogs LIPKA, ELKE TSRL, INC. MI $999,700
Emerging Infectious Diseases 2017 NIAID 5R21AI121664-02 Development of anti-virulence drugs by targeting the SaeRS two component system of Staphylococcus aureus BAE, TAEOK INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $165,974
Emerging Infectious Diseases 2017 NIAID 5R01AI122528-02 Regulation of Gammaherpesviral Late Gene Expression GLAUNSINGER, BRITT UNIVERSITY OF CALIFORNIA BERKELEY CA $370,256
Emerging Infectious Diseases 2017 NINDS 5F32NS095587-02 Characterizing the Cellular Biology of Prion Strains and the Factors that Drive Prion Pathogenesis LOPEZ, TIMOTHY UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $63,479
Emerging Infectious Diseases 2017 NIAID 5UM1AI069432-11 The UCSD CD4 Collaborative Clinical Trial Unit BENSON, CONSTANCE UNIVERSITY OF CALIFORNIA SAN DIEGO CA $2,370,023
Emerging Infectious Diseases 2017 NIAID 5R01AI118283-02 Function and inhibition of multidrug efflux systems in Campylobacter ZHANG, QIJING IOWA STATE UNIVERSITY IA $370,069
Emerging Infectious Diseases 2017 NIAID 5R01AI122672-02 Emerging flea-borne rickettsial diseases: vector competence and transmission biology MACALUSO, KEVIN LOUISIANA STATE UNIV A&M COL BATON ROUGE LA $370,000
Emerging Infectious Diseases 2017 NIAID 5R01AI122749-02 Antiviral immunity in the gut: how the intestinal epithelium and microbiota regulate infection CHERRY, SARA UNIVERSITY OF PENNSYLVANIA PA $394,288
Emerging Infectious Diseases 2017 NIAID 5UM1AI069439-12 Vanderbilt HIV Clinical Trials Unit HAAS, DAVID VANDERBILT UNIVERSITY MEDICAL CENTER TN $1,003,759
Emerging Infectious Diseases 2017 NIAID 5R01AI098686-05 The role of lysine methylation in regulating the motility of Toxoplasma gondii HU, KE INDIANA UNIVERSITY BLOOMINGTON IN $392,367
Emerging Infectious Diseases 2017 NIAID 5R01AI106893-03 Chlamydia virulence: exploitation of host N-glycosylation CAMPBELL, LEE UNIVERSITY OF WASHINGTON WA $386,250
Emerging Infectious Diseases 2017 FIC 5T37MD001424-13 Tulane Xavier Minority Training in International Health OBERHELMAN, RICHARD TULANE UNIVERSITY OF LOUISIANA LA $1,000
Emerging Infectious Diseases 2017 NIMHD 5T37MD001424-13 Tulane Xavier Minority Training in International Health OBERHELMAN, RICHARD TULANE UNIVERSITY OF LOUISIANA LA $136,818
Emerging Infectious Diseases 2017 NIAID 5UM1AI069412-11 Harvard/Boston/Providence Clinical Trials Unit (Harvard/B/P CTU) DOLIN, RAPHAEL BETH ISRAEL DEACONESS MEDICAL CENTER MA $3,046,726
Emerging Infectious Diseases 2017 NIAID 5UM1AI069494-11 PItt-Ohio State-Georgetown Clinical Trials Unit MELLORS, JOHN UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $1,491,683
Emerging Infectious Diseases 2017 NIAID 5UM1AI069496-11 San Francisco Bay Clinical Trials Unit BUCHBINDER, SUSAN PUBLIC HEALTH FOUNDATION ENTERPRISES CA $1,490,310
Emerging Infectious Diseases 2017 NIAID 5R01AI110937-03 Molecular basis and intervention of Staphylococcus aureus agglutination MISSIAKAS, DOMINIQUE UNIVERSITY OF CHICAGO IL $389,432
Emerging Infectious Diseases 2017 NIAID 5R01AI116496-03 The GCN5b acetylation complex in the AIDS pathogen Toxoplasma SULLIVAN, WILLIAM INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS IN $385,800
Emerging Infectious Diseases 2017 NIAID 5R01AI118861-02 Innate immune-mediated control of pulmonary Legionella pneumophila infection SHIN, SUNNY UNIVERSITY OF PENNSYLVANIA PA $400,000
Emerging Infectious Diseases 2017 NIAID 5R21AI121700-02 Synergistic Photodynamic Therapy for Catherer-Associated Urinary Tract Infections HAMBLIN, MICHAEL MASSACHUSETTS GENERAL HOSPITAL MA $228,995
Emerging Infectious Diseases 2017 NIAID 5R01AI104488-04 A Nurse Case Management Intervention to Improve MDR-TB/HIV Coinfection Outcomes FARLEY, JASON JOHNS HOPKINS UNIVERSITY MD $616,042
Emerging Infectious Diseases 2017 NIAID 5UM1AI069421-11 GHESKIO HIV Clinical Trial Unit PAPE, JEAN GHESKIO CENTER HAITI $1,030,670
Emerging Infectious Diseases 2017 NIAID 5UM1AI068634-11 Statistical and Data Management Center (SDMC), AIDS Clinical Trials Group (ACTG) HUGHES, MICHAEL HARVARD SCHOOL OF PUBLIC HEALTH MA $13,641,027
Emerging Infectious Diseases 2017 NIAID 5UM1AI069465-11 The Johns Hopkins Baltimore-Washington-India Clinical Trials Unit (BWI CTU) FLEXNER, CHARLES JOHNS HOPKINS UNIVERSITY MD $1,987,063
Emerging Infectious Diseases 2017 NIAID 5UM1AI069476-10 The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit GRINSZTEJN, BEATRIZ FUNDACAO OSWALDO CRUZ BRAZIL $74,365
Emerging Infectious Diseases 2017 NIAID 5R01AI108917-04 Impaired T cell immunity in the Elderly via enhanced N-glycosylation. DEMETRIOU, MICHAEL UNIVERSITY OF CALIFORNIA-IRVINE CA $461,402
Emerging Infectious Diseases 2017 NIAID 5R01AI110575-03 The mammalian small RNA machinery and its role in antiviral defenses TENOEVER, BENJAMIN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $418,258
Emerging Infectious Diseases 2017 NIEHS 5R01ES015050-12 Combustion Generated Particulate Pollution Affects Infant Respiratory Health CORMIER, STEPHANIA UNIVERSITY OF TENNESSEE HEALTH SCI CTR TN $324,042
Emerging Infectious Diseases 2017 NHLBI 5R01HL118390-04 Membrane Serine Protease Activities in Protease Activated Receptor Signaling ANTALIS, TONI UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Emerging Infectious Diseases 2017 NIAID 5R01AI084913-08 Mucosal T Cell Memory to Pathogens MASOPUST, DAVID UNIVERSITY OF MINNESOTA MN $380,000
Emerging Infectious Diseases 2017 NIAID 5UM1AI069422-11 South African Medical Research Council Clinical Trials Unit (MRC CTU) RAMJEE, GITA MEDICAL RESEARCH COUNCIL OF SOUTH AFRICA SO AFR $1,084,670
Emerging Infectious Diseases 2017 NIAID 5R01AI111095-03 HBGA receptors in host cell entry and infection of norovirus JIANG, WEN PURDUE UNIVERSITY IN $489,779
Emerging Infectious Diseases 2017 NIAID 5R01AI114557-03 Neutralizing Antibodies in Acute and Persistent Epstein-Barr Virus Infection WANG, FREDERICK BRIGHAM AND WOMEN'S HOSPITAL MA $593,287
Emerging Infectious Diseases 2017 NIAAA 5P60AA009803-24 7723 RC4: Alcohol & HIV-associated cancer pathogenesis PARSONS, CHRISTOPHER LSU HEALTH SCIENCES CENTER LA $45,905
Emerging Infectious Diseases 2017 NIAID 5R01AI058072-12 Structural Basis for Chemokine Function VOLKMAN, BRIAN MEDICAL COLLEGE OF WISCONSIN WI $344,250
Emerging Infectious Diseases 2017 NIAID 5UM1AI069519-11 University of Cape Town Clinical Trials Unit (UCTCTU) BEKKER, LINDA-GAIL UNIVERSITY OF CAPE TOWN SO AFR $1,749,653
Emerging Infectious Diseases 2017 NIAID 5UM1AI069418-11 Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit LENNOX, JEFFREY EMORY UNIVERSITY GA $2,403,962
Emerging Infectious Diseases 2017 NIAID 5R01AI101171-06 Host-mediated zinc sequestration during Acinetobacter baumannii infection SKAAR, ERIC VANDERBILT UNIVERSITY MEDICAL CENTER TN $464,778
Emerging Infectious Diseases 2017 NIAID 5R21AI121644-02 Development of the RNA molecule-enriched, cell type-specific exosomes JIN, YANG BOSTON UNIVERSITY MEDICAL CAMPUS MA $222,075
Emerging Infectious Diseases 2017 NIAID 5R21AI121669-02 Engineering “Phagebody” Antimicrobials for Carbapenem-Resistant Enterobacteriaceae LU, TIMOTHY MASSACHUSETTS INSTITUTE OF TECHNOLOGY MA $213,383
Emerging Infectious Diseases 2017 NIAID 5R01AI099489-06 The multiple states of IpaB Shigella type III secretion PICKING, WILLIAM UNIVERSITY OF KANSAS LAWRENCE KS $431,860
Emerging Infectious Diseases 2017 NIAID 5R01AI118224-02 Small-Molecule Antibiotics Targeting Siderophore Biosynthesis in M. tuberculosis TAN, DEREK SLOAN-KETTERING INST CAN RESEARCH NY $666,740
Emerging Infectious Diseases 2017 NIAID 5R21AI121704-02 Microbial-ecology guided discovery of non-traditional therapeutics that limit resistance KWAN, JASON UNIVERSITY OF WISCONSIN-MADISON WI $181,966
Emerging Infectious Diseases 2017 NIAID 5R01AI113720-03 Neutrophil Function in Bacterial Pneumonia JEYASEELAN, SAMITHAMBY LOUISIANA STATE UNIV A&M COL BATON ROUGE LA $369,629
Emerging Infectious Diseases 2017 NIAID 5R01AI116420-02 New antifungals targeting the synthesis of fungal sphingolipids DEL POETA, MAURIZIO STATE UNIVERSITY NEW YORK STONY BROOK NY $594,484
Emerging Infectious Diseases 2017 NIDA 5R01DA035146-05 HIV, HCV and STI Risk Associated with Nonmedical Use of Prescription Opioids MATEU-GELABERT, PEDRO NATIONAL DEVELOPMENT & RES INSTITUTES NY $550,788
Emerging Infectious Diseases 2017 FIC 5K01TW009484-05 A Study of Enteropathogenic Bacteria Transmitted from Animals to Humans GRAHAM, JAY PUBLIC HEALTH INSTITUTE CA $133,650
Emerging Infectious Diseases 2017 NIAID 5UM1AI069469-11 CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment ABDOOL KARIM, QUARRAISHA CENTRE/AIDS PROGRAMME/RES/SOUTH AFRICA SO AFR $1,311,319
Emerging Infectious Diseases 2017 NIAID 5R01AI040996-19 Mechanisms of anti-fungal Vaccine immunity KLEIN, BRUCE UNIVERSITY OF WISCONSIN-MADISON WI $568,031
Emerging Infectious Diseases 2017 NIAID 5R01AI116119-03 Salmonella, colonization resistance, and fructose-asparagine AHMER, BRIAN OHIO STATE UNIVERSITY OH $496,625
Emerging Infectious Diseases 2017 NIAID 5R01AI118389-03 Vaccines Against Botulism BARBIERI, JOSEPH MEDICAL COLLEGE OF WISCONSIN WI $593,592
Emerging Infectious Diseases 2017 NIAID 5R01AI079411-08 An Integrated System for the Epidemiological Application of Earth Observation Tec WIMBERLY, MICHAEL SOUTH DAKOTA STATE UNIVERSITY SD $362,500
Emerging Infectious Diseases 2017 NIAID 5UM1AI069521-11 Stellenbosch University Clinical Trials Unit (SUN-CTU) COTTON, MARK STELLENBOSCH UNIVERSITY TYGERBERG CAMPUS SO AFR $1,287,739
Emerging Infectious Diseases 2017 NIAID 5R01AI076457-09 T Cell Response to Listeria Monocytogenes Infection SHERIDAN, BRIAN STATE UNIVERSITY NEW YORK STONY BROOK NY $392,571
Emerging Infectious Diseases 2017 NIAID 5R01AI095309-05 Mucosal live vector vaccine against recurrent Clostridium difficile infections GALEN, JAMES UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Emerging Infectious Diseases 2017 NIAID 5R01AI110719-03 Role of sub-activation-threshold TCR interactions in maintaining T cell memory SINGH, NEVIL UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Emerging Infectious Diseases 2017 OD 5R01AI110719-03 Role of sub-activation-threshold TCR interactions in maintaining T cell memory SINGH, NEVIL UNIVERSITY OF MARYLAND BALTIMORE MD $192,888
Emerging Infectious Diseases 2017 NIAID 5R01AI114675-03 A High-Throughput Screen for Antiviral Inhibitors of the Alphavirus RNA Capping Enzyme GEISS, BRIAN COLORADO STATE UNIVERSITY CO $371,750
Emerging Infectious Diseases 2017 NIAID 5UM1AI069503-11 Terry Beirn CPCRA Clinical Trials Unit GORDIN, FRED GEORGE WASHINGTON UNIVERSITY DC $4,875,952
Emerging Infectious Diseases 2017 NIAID 5R01AI103440-05 A molecular basis for control of T cell memory HEDRICK, STEPHEN UNIVERSITY OF CALIFORNIA SAN DIEGO CA $465,000
Emerging Infectious Diseases 2017 NIAID 5R37AI042347-22 Molecular Biology and Virulence of CTX Phage WALDOR, MATTHEW BRIGHAM AND WOMEN'S HOSPITAL MA $419,338
Emerging Infectious Diseases 2017 NIAID 5R01AI121452-02 Trajectory of Vector-adaptive Chikungunya Virus Evolution WEAVER, SCOTT UNIVERSITY OF TEXAS MED BR GALVESTON TX $454,141
Emerging Infectious Diseases 2017 NIAID 5R01AI108906-04 Telomere Damage Responses and Immune Aging WEYAND, CORNELIA STANFORD UNIVERSITY CA $434,419
Emerging Infectious Diseases 2017 NIDA 5P30DA011041-20 5121 Infectious Diseases and Biomedical Core PERLMAN, DAVID NEW YORK UNIVERSITY NY $145,226
Emerging Infectious Diseases 2017 NIAID 5UM1AI069438-11 IMPACTA PERU CLINICAL TRIALS UNIT LAMA, JAVIER ASOCIACION CIVIL IMPACTA SALUD Y EDUCACN PERU $1,691,063
Emerging Infectious Diseases 2017 NIAID 5R01AI099483-05 Mosquito Saliva in Dengue Virus Pathogenesis RICO-HESSE, REBECCA BAYLOR COLLEGE OF MEDICINE TX $491,188
Emerging Infectious Diseases 2017 NIAID 5R21AI121662-02 A biotherapeutic CRISPR-delivery platform to eradicate Clostridium difficile VAN PIJKEREN, JAN-PETER UNIVERSITY OF WISCONSIN-MADISON WI $166,482
Emerging Infectious Diseases 2017 NIAID 5R01AI122753-02 Systematic evaluation of B. pertussis ACT’s role as a protective antigen MAYNARD, JENNIFER UNIVERSITY OF TEXAS, AUSTIN TX $376,277
Emerging Infectious Diseases 2017 NIAID 5R01AI103055-04 Innate and early B cell responses to V. cholerae HARRIS, JASON MASSACHUSETTS GENERAL HOSPITAL MA $759,607
Emerging Infectious Diseases 2017 NIAID 5UM1AI104681-05 Antibacterial Resistance Leadership Group (ARLG) FOWLER, VANCE DUKE UNIVERSITY NC $8,000,000
Emerging Infectious Diseases 2017 NIAID 5R01AI109843-04 Centrosome control of Toxoplasma growth WHITE, MICHAEL UNIVERSITY OF SOUTH FLORIDA FL $461,533
Emerging Infectious Diseases 2017 NIAID 5R21AI121614-02 Development of HAMLET as a Adjuvant for the Treatment of Drug-resistant Staphylococcus Aureus Infections EDWARDS, KATIE CUBRC, INC. NY $198,948
Emerging Infectious Diseases 2017 NIAID 5R21AI121639-02 Small Molecule Inhibition of Pilus Biogenesis by Pathogenic Bacteria THANASSI, DAVID STATE UNIVERSITY NEW YORK STONY BROOK NY $211,391
Emerging Infectious Diseases 2017 NCI 5R01CA041101-32 Biologically Active Cyclic Peptides BOGER, DALE SCRIPPS RESEARCH INSTITUTE CA $411,469
Emerging Infectious Diseases 2017 NIDCR 5R01DE025567-02 Atomic structure of Kaposi's sarcoma-associated herpesvirus capsid ZHOU, Z UNIVERSITY OF CALIFORNIA LOS ANGELES CA $385,000
Emerging Infectious Diseases 2017 NIAID 5UM1AI069470-11 Columbia Partnership for Prevention and Control of HIV/AIDS Clinical Trials Unit HAMMER, SCOTT COLUMBIA UNIVERSITY HEALTH SCIENCES NY $2,150,863
Emerging Infectious Diseases 2017 NIAID 5R01AI116791-02 Vaccine to prevent E. coli urinary tract infection MOBLEY, HARRY UNIVERSITY OF MICHIGAN MI $387,933
Emerging Infectious Diseases 2017 NIAID 5R21AI120972-02 BRASL - A rapid Barcoded RNA Annealing, Selection, and Ligation assay to detect pathogens. CHOW, ERIC UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $192,427
Emerging Infectious Diseases 2017 NIAID 5R01AI121430-02 Rapid Identification of Optimal Combination Regimens for Pseudomonas aeruginosa DRUSANO, GEORGE UNIVERSITY OF FLORIDA FL $729,901
Emerging Infectious Diseases 2017 NIAID 5R21AI121365-02 A Novel Screen for Antibacterials that Are Non-Toxic to Mammals DETWEILER, CORRELLA UNIVERSITY OF COLORADO CO $225,203
Emerging Infectious Diseases 2017 NIAID 5R21AI121581-02 Development of Novel Resistance-Modifying Agents for MRSA WANG, XIANG UNIVERSITY OF COLORADO CO $225,095
Emerging Infectious Diseases 2017 NIAID 5R21AI121627-02 Harnessing bacteriophages as natural predators to combat the superbugs: a pulmonary drug delivery approach CHAN, KIM UNIVERSITY OF SYDNEY AUSTRA $169,220
Emerging Infectious Diseases 2017 NIAID 5UM1AI106701-04 Laboratory Center, AIDS Clinical Trials Group (ACTG); LC 2 / 3 COOMBS, ROBERT BRIGHAM AND WOMEN'S HOSPITAL MA $6,624,131
Emerging Infectious Diseases 2017 NIAID 5R21AI121685-02 Phage depolymerases as antibiotics BULL, JAMES UNIVERSITY OF TEXAS, AUSTIN TX $197,625
Emerging Infectious Diseases 2017 NIAID 5UM1AI069453-11 KARABELO Clinical Trials Unit for NIAID Networks GRAY, GLENDA WITS HEALTH CONSORTIUM (PTY), LTD SO AFR $1,366,759
Emerging Infectious Diseases 2017 NIAID 5R21AI121684-02 Polymeric Agents for the Treatment of Clostridium difficile Infections MCBRIDE, SHONNA EMORY UNIVERSITY GA $214,127
Emerging Infectious Diseases 2017 NIAID 5R01AI077703-10 Physical Principles of Bacterial Toxin Translocation across Membranes KRANTZ, BRYAN UNIVERSITY OF MARYLAND BALTIMORE MD $383,750
Emerging Infectious Diseases 2017 NIAID 5UM1AI069463-11 Clinical Trials Units for NIAID Networks (UM1) SANNE, IAN WITS HEALTH CONSORTIUM (PTY), LTD SO AFR $1,051,232
Emerging Infectious Diseases 2017 NIAID 5R21AI121522-02 Defined microbial communities for the treatment of recurrent C. difficile infection BRITTON, ROBERT BAYLOR COLLEGE OF MEDICINE TX $194,278
Emerging Infectious Diseases 2017 NIAID 5R01AI122232-03 Spore Assembly in Clostridium Difficile SHEN, AIMEE TUFTS UNIVERSITY BOSTON MA $408,675
Emerging Infectious Diseases 2017 NIAID 5F32AI112208-03 Analysis of molecular factors influencing variability of mosquito gut microbiota SHORT, SARAH JOHNS HOPKINS UNIVERSITY MD $60,990
Emerging Infectious Diseases 2017 NIAID 5R01AI107022-02 Innate Effectors and Type-2 Inflammation HUANG, HUA NATIONAL JEWISH HEALTH CO $396,250
Emerging Infectious Diseases 2017 NIAID 5K22AI108600-02 Visualizing Influenza Viral RNA Packaging LAKDAWALA, SEEMA UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $107,787
Emerging Infectious Diseases 2017 NIAID 5R21AI121590-02 A safe, targeted, designer probiotic to prevent or treat C. difficile infection VEDANTAM, GAYATRI UNIVERSITY OF ARIZONA AZ $184,516
Emerging Infectious Diseases 2017 NIAID 5F31AI112288-03 Characteristics of the larval habitat and the spread of invasive disease vectors BRABANT, PETER ILLINOIS STATE UNIVERSITY IL $23,428
Emerging Infectious Diseases 2017 NIAID 5R01AI100569-04 Optimizing ELQs for Treatment and Prevention of Malaria RISCOE, MICHAEL OREGON HEALTH & SCIENCE UNIVERSITY OR $613,423
Emerging Infectious Diseases 2017 NIDCR 5R01DE022069-05 The role of Candida albicans biofilms in a novel rat model of denture stomatitis NOVERR, MAIRI LSU HEALTH SCIENCES CENTER LA $354,859
Emerging Infectious Diseases 2017 NIGMS 5R01GM094510-07 Dynamics of Antimicrobial Peptide Interactions with Bacterial Membranes WEISSHAAR, JAMES UNIVERSITY OF WISCONSIN-MADISON WI $294,128
Emerging Infectious Diseases 2017 NIAID 5R01AI083311-07 The transcriptional circuitry controlling biofilm development in Candida albicans JOHNSON, ALEXANDER UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $475,560
Emerging Infectious Diseases 2017 NIAID 5R01AI087644-07 Synaptic Control of Cytotoxic T cell Function HUSE, MORGAN SLOAN-KETTERING INST CAN RESEARCH NY $416,276
Emerging Infectious Diseases 2017 NIAID 5R01AI033537-22 Virulence gene expression by Bacillus anthracis KOEHLER, THERESA UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $346,500
Emerging Infectious Diseases 2017 NIAID 5R01AI056312-11 Function of antimalarial drug resistance proteins ROEPE, PAUL GEORGETOWN UNIVERSITY DC $413,757
Emerging Infectious Diseases 2017 NIAID 5R21AI121692-02 Development of Modified R-type Bacteriocins to Specifically Target C. difficile and Prevent Relapse of CDIs SCHOLL, DEAN AVIDBIOTICS CORPORATION CA $119,517
Emerging Infectious Diseases 2017 NIAID 5R21AI121604-02 Therapeutic Potential of Cystatin 9 Treatment to Fight Bacterial Pneumonia EAVES-PYLES, TONYIA UNIVERSITY OF TEXAS MED BR GALVESTON TX $176,127
Emerging Infectious Diseases 2017 NEI 5R01AI121207-02 Naturally-Acquired and Vaccine-Mediated Immunity to Leptospirosis KO, ALBERT YALE UNIVERSITY CT $613,480
Emerging Infectious Diseases 2017 NIAID 5R01AI121207-02 Naturally-Acquired and Vaccine-Mediated Immunity to Leptospirosis KO, ALBERT YALE UNIVERSITY CT $700,287
Emerging Infectious Diseases 2017 NIAID 5R01AI121401-02 Multiple B. burgdorferi Factors Collaborate to Evade Complement-Mediated Defenses LEONG, JOHN TUFTS UNIVERSITY BOSTON MA $629,219
Emerging Infectious Diseases 2017 NIAID 5R21AI121575-02 Microbes that Matter: defining optimal formulations for Microbial Ecosystem Therapeutics PETROF, ELAINE QUEEN'S UNIVERSITY AT KINGSTON CANADA $148,500
Emerging Infectious Diseases 2017 NCI 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $100,000
Emerging Infectious Diseases 2017 NIAID 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $49,153,075
Emerging Infectious Diseases 2017 NIDA 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Emerging Infectious Diseases 2017 NINDS 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $1,000,000
Emerging Infectious Diseases 2017 OD 5UM1AI068636-11 Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/ KURITZKES, DANIEL BRIGHAM AND WOMEN'S HOSPITAL MA $2,899,810
Emerging Infectious Diseases 2017 NIAID 5R01AI110577-03 Dynamics of Hepatis C viral RNA-dependent RNA replication JOHNSON, KENNETH UNIVERSITY OF TEXAS, AUSTIN TX $453,213
Emerging Infectious Diseases 2017 NIAID 5R21AI121545-02 Bacteriophage to treat UTI caused by multidrug-resistant P. aeruginosa RAMIG, ROBERT BAYLOR COLLEGE OF MEDICINE TX $217,938
Emerging Infectious Diseases 2017 NIDDK 5F32DK104516-03 Understanding the role of inflammation, fibrinogen and neutrophils in persistence of E. faecalis during CAUTI FLORES-MIRELES, ANA WASHINGTON UNIVERSITY MO $60,990
Emerging Infectious Diseases 2017 NIAID 5K08AI102761-05 Mechanisms of Neutralizing Antibody Resistance in Chronic HCV and HIV Infection BAILEY, JUSTIN JOHNS HOPKINS UNIVERSITY MD $195,063
Emerging Infectious Diseases 2017 NIAID 5R01AI114873-03 ZAP isoforms in innate immunity-the long, the short and the extra-long of it all MACDONALD, MARGARET ROCKEFELLER UNIVERSITY NY $423,750
Emerging Infectious Diseases 2017 NIAID 5R01AI109139-03 Prophylaxis of Clostridium difficile infection ABEL-SANTOS, ERNESTO UNIVERSITY OF NEVADA LAS VEGAS NV $639,084
Emerging Infectious Diseases 2017 NIAID 5R01AI110481-03 MACROPHAGE FATTY ACID METABOLISM IN IMMUNITY TO HELMINTHS PEARCE, EDWARD INSTITUT FUR IMMUNBIOLOGIE/EPIGENETIK GERM $270,000
Emerging Infectious Diseases 2017 NIAID 5R01AI072571-11 Molecular Control of Plasmacytoid Dendritic Cell Development and Function REIZIS, BORIS NEW YORK UNIVERSITY SCHOOL OF MEDICINE NY $423,750
Emerging Infectious Diseases 2017 NIAID 5UM1AI069423-11 University of North Carolina Global HIV Prevention and Treatment Clinical Trials ERON, JOSEPH UNIV OF NORTH CAROLINA CHAPEL HILL NC $2,644,627
Emerging Infectious Diseases 2017 NIAID 5R01AI080710-07 Role of PA4878 in biofilm antimicrobial resistance SAUER, KARIN STATE UNIVERSITY OF NY,BINGHAMTON NY $315,395
Emerging Infectious Diseases 2017 NIAID 5K08AI108792-03 Burkholderia-mediated defective killing mechanisms in macrophages from cystic fibrosis (CF) patients KOPP, BENJAMIN RESEARCH INST NATIONWIDE CHILDREN'S HOSP OH $176,504
Emerging Infectious Diseases 2017 NHLBI 5R01HL122426-03 Immunopathogenesis in fungal asthma STEELE, CHAD UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $431,146
Emerging Infectious Diseases 2017 NIAID 5R01AI116025-03 Host and microbial factors promoting synergistic mortality during polymicrobial intra-abdominal infections with Candida albicans and Staphylococcus aureus NOVERR, MAIRI LSU HEALTH SCIENCES CENTER LA $365,000
Emerging Infectious Diseases 2017 NIAID 5R01AI079336-08 The Role of STING in Innate Immunity BARBER, GLEN UNIVERSITY OF MIAMI SCHOOL OF MEDICINE FL $421,069
Emerging Infectious Diseases 2017 NIAID 5R01AI104660-05 Therapeutics for Drug-Resistant Bacteria: Pseudouridimycins EBRIGHT, RICHARD RUTGERS, THE STATE UNIV OF N.J. NJ $1,021,724
Emerging Infectious Diseases 2017 NIAID 5R21AI121531-02 Towards the Development of Engineered Phage Therapeutics against MDR Pathogens BARBU, ELENA SYNTHETIC GENOMICS VACCINES, INC. CA $189,526
Emerging Infectious Diseases 2017 NIAID 5R01AI078881-07 Collaborative Integration of HCV Molecular Virology and Mathematical Modeling UPRICHARD, SUSAN LOYOLA UNIVERSITY CHICAGO IL $531,399
Emerging Infectious Diseases 2017 NIAID 5R01AI087846-07 Regulation of Host Innate Immunity Against Viral Infection GACK, MICHAELA UNIVERSITY OF CHICAGO IL $389,432
Emerging Infectious Diseases 2017 NIAID 5R01AI116523-02 Ubiquitylation and Rickettsial Colonization of a Tick Vector PEDRA, JOAO UNIVERSITY OF MARYLAND BALTIMORE MD $539,729
Emerging Infectious Diseases 2017 NIAID 5R01AI117210-02 Exploring Peptide Conjugates as Trojan Horse Systems for Drug Design and Discovery NAIR, SATISH UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN IL $481,992
Emerging Infectious Diseases 2017 NIAID 5R01AI122344-02 Antigen-specific B cell tolerance in the gut-associated lymphoid tissue (GALT) APGAR, JOHN SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CA $487,500
Emerging Infectious Diseases 2017 NIAID 5R01AI037856-16 M.tb Survival Regulatory Genes BISHAI, WILLIAM JOHNS HOPKINS UNIVERSITY MD $521,301
Emerging Infectious Diseases 2017 NIAID 5R01AI097511-05 Pseudomonas biofilms and immunity WOZNIAK, DANIEL OHIO STATE UNIVERSITY OH $385,381
Emerging Infectious Diseases 2017 NIAID 5R01AI074951-10 The role of autophagy in innate anti-viral immunity in Drosophila CHERRY, SARA UNIVERSITY OF PENNSYLVANIA PA $400,000
Emerging Infectious Diseases 2017 NIAID 5R01AI121337-02 SIGNALING MECHANISMS IN VIBRIO CHOLERAE PARALLEL QUORUM SENSING PATHWAYS NG, WAI-LEUNG TUFTS UNIVERSITY BOSTON MA $409,383
Emerging Infectious Diseases 2017 NIAID 5R01AI121558-02 Variation in Resistance and Fitness to Artemisinins in African Malaria JULIANO, JONATHAN UNIV OF NORTH CAROLINA CHAPEL HILL NC $632,307
Emerging Infectious Diseases 2017 NIAID 5R01AI120607-02 ENDOLYSOSOMAL FUNCTION IN CHRONIC TOXOPLASMA INFECTION CARRUTHERS, VERNON UNIVERSITY OF MICHIGAN MI $357,420
Emerging Infectious Diseases 2017 NIAID 5K22AI116509-02 Survival of influenza A virus infected cells and effects on pathogenesis HEATON, NICHOLAS DUKE UNIVERSITY NC $104,514
Emerging Infectious Diseases 2017 NIAID 5R01AI116605-02 Mechanisms of Mycobacterium Tuberculosis pH-driven Adaptation ABRAMOVITCH, ROBERT MICHIGAN STATE UNIVERSITY MI $380,779
Emerging Infectious Diseases 2017 NHLBI 5R01HL086392-08 Mechanism of Gating and Permeation in The TRKH K+ Channels ZHOU, MING BAYLOR COLLEGE OF MEDICINE TX $391,058
Emerging Infectious Diseases 2017 NIAID 5R37AI044005-19 Antigenic variation in microbial transmission PALMER, GUY WASHINGTON STATE UNIVERSITY WA $339,750
Emerging Infectious Diseases 2017 NIAID 5R01AI104972-05 ISG CONTROL OF FLAVIVIRUS INFECTION DIAMOND, MICHAEL WASHINGTON UNIVERSITY MO $582,216
Emerging Infectious Diseases 2017 NIAID 5R01AI108765-04 Novel regulatory mechanisms control IFNL3 expression during HCV infection SAVAN, RAM UNIVERSITY OF WASHINGTON WA $514,747
Emerging Infectious Diseases 2017 NIAID 5R01AI099002-05 Bacterial effectors targeting the IKK/NF-kB pathway HARDWIDGE, PHILIP KANSAS STATE UNIVERSITY KS $375,000
Emerging Infectious Diseases 2017 NIAID 5U01AI115715-03 Mucosal and Systemic Immune Responses to Influenza Virus GREENBERG, HARRY PALO ALTO VETERANS INSTIT FOR RESEARCH CA $427,852
Emerging Infectious Diseases 2017 NCI 5R01CA171979-05 Genome Persistence of KSHV ROBERTSON, ERLE UNIVERSITY OF PENNSYLVANIA PA $298,800
Emerging Infectious Diseases 2017 NIAID 5R01AI112445-03 Exacerbation of colitis by Enterobacteriaceae BAUMLER, ANDREAS UNIVERSITY OF CALIFORNIA AT DAVIS CA $392,500
Emerging Infectious Diseases 2017 NIAID 5R01AI053067-15 Quorum sensing regulation of EHEC virulence genes SPERANDIO, VANESSA UT SOUTHWESTERN MEDICAL CENTER TX $546,834
Emerging Infectious Diseases 2017 NIAID 5R01AI113221-03 Modulating Immunity to Nucleic Acids and Inducing Tolerance by Gene Transfer BROWN, BRIAN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $421,004
Emerging Infectious Diseases 2017 NIAID 5R01AI118502-02 Sensitive and quantitative point-of-care viral load testing on paper SHAFIEE, HADI BRIGHAM AND WOMEN'S HOSPITAL MA $425,150
Emerging Infectious Diseases 2017 NIGMS 5R01GM104540-05 Structure and function of prokaryotic appendages by cryo-electron tomography WRIGHT, ELIZABETH EMORY UNIVERSITY GA $273,854
Emerging Infectious Diseases 2017 NLM 5F31LM012176-02 Integrating Bioinformatics and Clustering Analysis for Disease Surveillance BEARD, RACHEL ARIZONA STATE UNIVERSITY-TEMPE CAMPUS AZ $38,800
Emerging Infectious Diseases 2017 NIAID 5R01AI113186-03 Multi-level analysis of influenza virus polymerase and its role in pathogenesis MARAZZI, IVAN ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI NY $595,386
Emerging Infectious Diseases 2017 NIAID 5R01AI116787-03 Comparative Effectiveness/Implementation of TB Case Finding in Rural South Africa DOWDY, DAVID JOHNS HOPKINS UNIVERSITY MD $600,728
Emerging Infectious Diseases 2017 NIAID 5R01AI118999-02 Regulation of Staphylococcus aureus physiology by bacterial nitric oxide RICE, KELLY UNIVERSITY OF FLORIDA FL $329,019
Emerging Infectious Diseases 2017 NIAID 5R01AI114855-03 Elucidating Genetic Determinants of Resistance to Lassa Hemorrhagic Fever SABETI, PARDIS BROAD INSTITUTE, INC. MA $756,479
Emerging Infectious Diseases 2017 NHLBI 5R01HL122760-03 IL-22: A therapeutic cytokine for the amelioration of pulmonary influenza injury POCIASK, DEREK TULANE UNIVERSITY OF LOUISIANA LA $367,497
Emerging Infectious Diseases 2017 NIAID 5F31AI112272-03 Mechanisms of ARF6 function in Shigella entry GARZA-MAYERS, ANNA HARVARD MEDICAL SCHOOL MA $17,647
Emerging Infectious Diseases 2017 NIAID 5R01AI104914-05 Innate immunity and Salmonella pathogenesis BARTON, GREGORY UNIVERSITY OF CALIFORNIA BERKELEY CA $353,250
Emerging Infectious Diseases 2017 NIAID 5R01AI041139-19 Innate Immune Responses to Malaria Parasites GOWDA, CHANNE PENNSYLVANIA STATE UNIV HERSHEY MED CTR PA $429,090
Emerging Infectious Diseases 2017 NIAID 5R01AI050237-15 Translation Regulation by Enterovirus Proteinase LLOYD, RICHARD BAYLOR COLLEGE OF MEDICINE TX $391,250
Emerging Infectious Diseases 2017 NIAID 5R01AI119022-03 Structure and mechanism of the ESX secretion system from pathogenic mycobacteria KOROTKOV, KONSTANTIN UNIVERSITY OF KENTUCKY KY $376,250
Emerging Infectious Diseases 2017 NIAID 5R01AI110480-03 Regulation of T-cell dependent B cell responses to influenza BALLESTEROS-TATO, ANDRE UNIVERSITY OF ALABAMA AT BIRMINGHAM AL $367,500
Emerging Infectious Diseases 2017 NIAID 5R01AI116943-02 A systematic analysis of small RNA interactions during RNA virus infections RICE, CHARLES ROCKEFELLER UNIVERSITY NY $545,126
Emerging Infectious Diseases 2017 NIAID 5R01AI108907-04 Influenza vaccine failure in adults over age 75: role of chronic CMV infection LENG, SEAN JOHNS HOPKINS UNIVERSITY MD $624,028
Emerging Infectious Diseases 2017 NIAID 5R21AI120977-02 Real-Time Unbiased Pathogen Detection in Febrile Illnesses by Nanopore Sequencing CHIU, CHARLES UNIVERSITY OF CALIFORNIA, SAN FRANCISCO CA $237,750
Emerging Infectious Diseases 2017 NIAID 5R01AI114688-03 Genomic Epidemiology of Methicillin-Resistant Staphylococcus aureus in Jail POPOVICH, KYLE RUSH UNIVERSITY MEDICAL CENTER IL $376,642
Emerging Infectious Diseases 2017 OD 5R01AI114688-03 Genomic Epidemiology of Methicillin-Resistant Staphylococcus aureus in Jail POPOVICH, KYLE RUSH UNIVERSITY MEDICAL CENTER IL $116,087
Emerging Infectious Diseases 2017 NIAID 5R37AI063331-12 Cryopyrin/NLRP3 Signaling in Inflammation and Innate Immunity NUNEZ, GABRIEL UNIVERSITY OF MICHIGAN MI $387,500
Emerging Infectious Diseases 2017 NIAID 5R01AI110432-03 Post-initiation regulatory mechanisms controlling ethanolamine utilization GARSIN, DANIELLE UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON TX $456,020
Emerging Infectious Diseases 2017 NIAID 5R01AI121400-02 A Pharmacologic Approach to Prevent Daptomycin Resistance in VRE RYBAK, MICHAEL WAYNE STATE UNIVERSITY MI $385,000
Emerging Infectious Diseases 2017 NHLBI 5R37HL079142-13 Th17 Cytokines and Lung Immunity KOLLS, JAY UNIVERSITY OF PITTSBURGH AT PITTSBURGH PA $255,986
Emerging Infectious Diseases 2017 NIAID 5R01AI085051-08 Drug Resistance in HCV NS3/4A - Inhibitor binding versus substrate recognition SCHIFFER, CELIA UNIV OF MASSACHUSETTS MED SCH WORCESTER MA $588,464
Emerging Infectious Diseases 2017 NIAID 5R37AI047365-18 Structure and Function of the Hepatitis C Virus Genome SARNOW, PETER STANFORD UNIVERSITY CA $458,399
Emerging Infectious Diseases 2017 NIAID 5R01AI050611-13 A chicken model to study hepatitis E virus pathogenesis MENG, XIANG-JIN VIRGINIA POLYTECHNIC INST AND ST UNIV VA $392,874
Emerging Infectious Diseases 2017 NIAID 5R01AI104669-06 Development of IFN-lambda3 for the Prevention and Treatment of Virus Infection KOTENKO, SERGEI RBHS-NEW JERSEY MEDICAL SCHOOL NJ $1,190,331
12345678910...


  • Download Readers:
  • Download Adobe PDF Reader
  • Download Microsoft PowerPoint Viewer
  • Download Microsoft Word Viewer
  • Download Microsoft Excel Viewer